nach oben

Clinical & Experimental Metastasis

Erschienen in:

28.05.2018 | Research Paper

Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions

verfasst von: Michael T. Dellinger, Marlys H. Witte

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 5-6/2018

Einloggen, um Zugang zu erhalten

Abstract

Ever since it was discovered that endothelial cells line lymphatic vessels, investigators have been working on unraveling the mechanisms that control the growth of this distinctive endothelium and its role in normal physiology and human disease. Recent technological advances have ushered in a new era of “omics” research on the lymphatic system. Research on the genome, transcriptome, proteome, and metabolome of lymphatics has increased our understanding of the biology of the lymphatic vasculature. Here, we introduce the context—lymphatic “systemomics,” then briefly review some of the latest advances in research on tumor-associated lymphatic vessels highlighting several “omic” studies that have shed light on mechanisms controlling the growth and function of tumor-associated lymphatic vessels. We conclude by returning, with unanswered questions, to the larger context of cancer and the lymphatic system as a vasculature, circulation, route of entry and transport, and control center of the immune network.

Witte MH, Way DL, Witte CL, Bernas M (1997) Lymphangiogenesis: mechanisms, significance and clinical implications. In: Goldberg ID, Rosen EM (eds) Regulation of angiogenesis. Birkhäuser Verlag, Basel, pp 65–112CrossRef

Witte MH, Bernas M, Martin C, Witte CL (2001) Lymphangiogenesis and lymphangiodysplasias: from molecular to clinical lymphology. In: Wilting J (guest ed) The biology of lymphangiogenesis. Microsc Res Tech 55(2):122–145CrossRef

Casley-Smith JR, Florey HW (1961) The structure of normal small lymphatics. Q J Exp Physiol 46:101–106CrossRef

Kinmonth JB (ed) (1972) The lymphatics: diseases, lymphography and surgery. Edward Arnold, London

Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355(13):1307–1317CrossRef

Witte MH, Dumont AE, Cole WR, Witte CL, Kintner K (1969) Lymph circulation in hepatic cirrhosis: effect of portacaval shunt. Ann Int Med 70(2):303–310CrossRef

Witte MH, Dumont AE, Clauss RH, Rader B, Levine N, Breed E (1969) Lymph circulation in congestive heart failure: effect of external thoracic duct drainage. Circulation 39(6):723–733CrossRef

Triolo VA (1965) Nineteenth century foundations of cancer research: advances in tumor pathology, nomenclature, and theories of oncogenesis. Cancer Res 25(2):76–106

Mandal A (2013) History of breast cancer. News Medical Life Sciences. https://www.news-medical.net/health/History-of-Breast-Cancer.aspx

10.

Fisher B, Fisher ER (1968) Role of lymphatic system in dissemination of tumor. In: Mayerson HS (ed) Lymph and the lymphatic system. CC Thomas, New York, pp 324–347

11.

Folkman J (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29(6 Suppl 16):15–18CrossRef

12.

Bowman C, Witte MH, Witte CL, Way D, Nagle R, Copeland J, Daschbach C (1984) Cystic hygroma reconsidered: hamartoma or neoplasm? Primary culture of an endothelial cell line from a massive cervicomediastinal cystic hygroma with bony lymphangiomatosis. Lymphology 17(1):15–22PubMed

13.

Witte MH, Witte CL (1986) Lymphangiogenesis and lymphologic syndromes. Lymphology 19(1):21–28PubMed

14.

Witte MH, Witte CL (1997) On tumor (and other) lymphangiogenesis. Lymphology 30(1):1–2PubMed

15.

Van Netten JP, Cann SA, Van der Wethuizen NG (1996) Angiogenesis and tumor growth. N Engl J Med 334(26):920–921PubMed

16.

Ferrara N, Henzel WJ (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161(2):851–858CrossRef

17.

Dvorak HF (2006) Discovery of vascular permeability factor (VPF). Exp Cell Res 312(5):522–526CrossRef

18.

Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO 15(2):290–298CrossRef

19.

Achen MG, Jeltsch M, Kukk E, Mäkinen T, Vitali A, Wilks AF, Alitalo K et al (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGFR3 (Flt4). Proc Natl Acad Sci USA 95(2):548–553CrossRef

20.

Brouillard P, Boon L, Vikkulla M (2014) Genetics of lymphatic abnormalities. J Clin Investig 124(3):898–904CrossRef

21.

Mohammed RA, Martin SG, Gill S et al (2007) Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 3:825–833

22.

Arnaout-Alkarain A, Kahn HL, Narod SA et al (2007) Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer. Mod Pathol 20:83–89CrossRef

23.

Azalli G (2006) On the transendothelial passage of tumor cell from extravasal matrix into the lumen of absorbing lymphatic vessel. Microvasc Res 72:74–85CrossRef

24.

Burn J, Watne A, Moore G (1962) The role of the thoracic duct lymph in cancer dissemination. Br J Cancer 16:608–615CrossRef

25.

Klingen T, Chen Y, Stefansson IM, Knutsvik G, Collet K, Abrahamsen AL et al (2017) Tumour cell invasion into blood vessels is significantly related to breast cancer subtypes and decreased survival. J Clin Pathol 70:313–319CrossRef

26.

Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P et al (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7(2):192–198CrossRef

27.

Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R et al (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20(4):672–682CrossRef

28.

Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R et al (2001) VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7(2):186–191CrossRef

29.

Karpanen T, Alitalo K (2008) Molecular biology and pathology of lymphangiogenesis. Annu Rev Pathol 3:367–397CrossRef

30.

He Y, Kozaki K, Karpanen T, Koshikawa K, Yla-Herttuala S, Takahashi T et al (2002) Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94(11):819–825CrossRef

31.

Alitalo A, Detmar M (2012) Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31(42):4499–4508CrossRef

32.

Bo C, Xiaopeng D, Chuanliang P, Xiaogang Z (2009) Expression of vascular endothelial growth factors C and D correlates with lymphangiogenesis and lymph node metastasis in lung adenocarcinoma. Thorac Cardiovasc Surg 57(5):291–294CrossRef

33.

Feng Y, Wang W, Hu J, Ma J, Zhang Y, Zhang J (2010) Expression of VEGF-C and VEGF-D as significant markers for assessment of lymphangiogenesis and lymph node metastasis in non-small cell lung cancer. Anat Rec 293(5):802–812CrossRef

34.

Kadota K, Huang CL, Liu D, Ueno M, Kushida Y, Haba R et al (2008) The clinical significance of lymphangiogenesis and angiogenesis in non-small cell lung cancer patients. Eur J Cancer 44(7):1057–1067CrossRef

35.

Sun JG, Wang Y, Chen ZT, Zhuo WL, Zhu B, Liao RX et al (2009) Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value. J Exp Clin Cancer Res 28(1):21CrossRef

36.

Adachi Y, Nakamura H, Kitamura Y, Taniguchi Y, Araki K, Shomori K et al (2007) Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases. Pathol Int 57(4):171–177CrossRef

37.

Kajita T, Ohta Y, Kimura K, Tamura M, Tanaka Y, Tsunezuka Y et al (2001) The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 85(2):255–260CrossRef

38.

Thiele W, Sleeman JP (2006) Tumor-induced lymphangiogenesis: a target for cancer therapy? J Biotechnol 124(1):224–241CrossRef

39.

Gabor S, Renner H, Popper H, Anegg U, Sankin O, Matzi V et al (2004) Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer. Eur J Cardiothorac Surg 25:439–442CrossRef

40.

Kessler R, Gasser B, Massard G, Roeslin N, Meyer P, Wihlm JM et al (1996) Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg (62):1489–1493CrossRef

41.

Wang J, Chen J, Chen X, Wang B, Li K, Bi J (2011) Blood vessel invasion as a strong independent prognostic indicator in non-small cell lung cancer: a systematic review and meta-analysis. PLoS One 6(12):e28844CrossRef

42.

Wyckoff JB, Wang Y, Lin EY, Li J, Goswami S, Stanley ER et al (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67(6):2649–2656CrossRef

43.

Robinson BD, Sica GL, Liu YF, Rohan TE, Gertler FB, Condeelis JS, Jones JG (2009) Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15(7):2433–2441CrossRef

44.

Regan E, Sibley RC, Cenik BK, Silva A, Girard L, Minna JD et al (2016) Identification of gene expression differences between lymphangiogenic and non-lymphangiogenic non-small cell lung cancer cell lines. PLoS One 11(3):e0150963CrossRef

45.

Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M (2005) VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201(7):1089–1099CrossRef

46.

Hirakawa S, Brown LF, Kodama S, Paavonen K, Alitalo K, Detmar M (2007) VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109(3):1010–1017CrossRef

47.

Olmeda D, Cerezo-Wallis D, Riveiro-Falkenbach E, Pennacchi PC, Contreras-Alcalde M, Ibarz N et al (2017) Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine. Nature 546(7660):676–680CrossRef

48.

Morton DL (2012) Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma. Clin Exp Metastasis 29(7):699–706CrossRef

49.

McFadden DG, Papagiannakopoulos T, Taylor-Weiner A, Stewart C, Carter SL, Cibulskis K et al (2014) Genetic and clonal dissection of murine small cell lung carcinoma progression by genome sequencing. Cell 156(6):1298–1311CrossRef

50.

Pereira ER, Kedrin D, Seano G, Gautier O, Meijer EFJ, Jones D et al (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403–1407CrossRef

51.

Brown M, Assen FP, Leithner A, Abe J, Schachner H, Asfour G et al (2018) Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice. Science 359:1408–1411CrossRef

52.

Girard J, Moussion C, Forster R (2012) HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat Rev Immunol 12:762–773CrossRef

53.

Maisel K, Sasso MS, Potin L, Swartz MA (2017) Exploiting lymphatic vessels for immunomodulation: rationale, opportunities, and challenges. Adv Drug Deliv Rev 114:43–59CrossRef

54.

Lund AW, Duraes FV, Hirosue S, Raghavan VR, Nembrini C, Thomas SN et al (2012) VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep 1(3):191–199CrossRef

55.

Hirosue S, Vokali E, Raghavan VR, Rincon-Restrepo M, Lund AW, Corthesy-Henrioud P et al (2014) Steady-state antigen scavenging, cross-presentation, and CD8 + T cell priming: a new role for lymphatic endothelial cells. J Immunol 192(11):5002–5011CrossRef

56.

Dieterich LC, Ikenberg K, Cetintas T, Kapaklikaya K, Hutmacher C, Detmar M (2017) Tumor-associated lymphatic vessels upregulate PDL1 to inhibit T-cell activation. Front Immunol 8:66CrossRef

57.

Tewalt EF, Cohen JN, Rouhani SJ, Guidi CJ, Qiao H, Fahl SP et al (2012) Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 120(24):4772–4782CrossRef

58.

Fankhauser M, Broggi MAS, Potin L, Bordry N, Jeanbart L, Lund AW et al (2017) Tumor lymphangiogenesis promotes T cell infiltration and potentiates immunotherapy in melanoma. Sci Transl Med 9(407):eaal4712CrossRef

59.

Hendrix MJ, Seftor EA, Seftor RE, Chao J, Chu Y (2016) Tumor cell vascular mimicry: novel targeting opportunity in melanoma. Pharmacol Ther 159:83–92CrossRef

60.

Lederberg J, McCray AT (2001) ‘Ome, sweet ‘omics—a genealogical treasury of words. Scientist 15(7):8–9

61.

Greene J, Localzo J (2017) Putting the patient back together—social medicine, network medicine and the limits of reductionism. N Engl J Med 377(25):2493–2495CrossRef

62.

Bhat R, Bissell MJ (2014) Of plasticity and specificity: dialectics of the microenvironment and macroenvironment and the organ phenotype. Wiley Interdiscip Rev Dev Biol 3(2):147–163CrossRef

Titel: Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions
verfasst von: Michael T. Dellinger
Marlys H. Witte
Publikationsdatum: 28.05.2018
Verlag: Springer Netherlands
Erschienen in: Clinical & Experimental Metastasis / Ausgabe 5-6/2018
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI: https://doi.org/10.1007/s10585-018-9907-9

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Lymphangiogenesis, lymphatic systemomics, and cancer: context, advances and unanswered questions

Abstract

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5-6/2018

Editorial

Lymphedema following cancer therapy: overview and options

Update on the indications and results of sentinel node mapping in upper GI cancer

Cystatin C takes part in melanoma-microglia cross-talk: possible implications for brain metastasis

Sentinel node evaluation in prostate cancer

Alternative splicing and cancer metastasis: prognostic and therapeutic applications

Neu im Fachgebiet Onkologie

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Erhöhte Mortalität bei postpartalem Brustkrebs

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

Update Onkologie